Amgen unveils its KRas inhibitor in human clinical trials
Wednesday, April 3, 2019 - 13:10
in Health & Medicine
AMG 510 shuts down a mutant version of the cancer target via covalent interaction
Updated by artificial intelligence Tue, 13 Jun 2023, 2:53:47 UTC Learn more
- Tell your friends
- Get science news via